Our Services

Get 15% Discount on your First Order

Post a 260- to 350-word response to the following questions as a New Message into the discussion area:Drug companies are pursuing collaborative efforts with other companies to manage in the world of p

August 26, 2023

Post a 260- to 350-word response to the following questions as a New Message into the discussion area:

Drug companies are pursuing collaborative efforts with other companies to manage in the world of pharmacogenomics and individualized medicine.
- What are some examples of these collaborative efforts being pursued by pharmaceutical companies?
- The National Institute of Health is establishing collaborative efforts through the Accelerated Medical Partnership (AMP) program. What is AMP, and how is this working?

Cite at least 1 peer-reviewed, scholarly, or similar reference.

Format your citations according to APA guidelines.

Expert Solution Preview

Pharmaceutical companies are increasingly engaging in collaborative efforts to navigate the evolving landscape of pharmacogenomics and individualized medicine. Such collaborations allow companies to pool resources, expertise, and technologies to accelerate research and development processes, while also improving patient outcomes. Here are some examples of collaborative efforts being pursued by pharmaceutical companies:

1. Public-Private Partnerships: Many pharmaceutical companies are collaborating with public organizations, such as government agencies or research institutions, to advance pharmacogenomics initiatives. These partnerships aim to leverage the strengths of both sectors, combining industry knowledge and resources with the scientific expertise and research capabilities of public organizations. For instance, Pfizer has partnered with the National Cancer Institute (NCI) to explore personalized cancer therapies through the NCI-MATCH (Molecular Analysis for Therapy Choice) program.

2. Consortia and Alliances: Pharmaceutical companies are also joining forces through consortia and alliances, forming collaborative networks to address shared challenges and develop innovative solutions. These initiatives typically involve multiple industry players, academic institutions, and regulatory bodies working together to advance research and development in specific therapeutic areas or technologies. One notable example is the Multiple Myeloma Research Foundation (MMRF) CoMMpass Study, which brings together pharmaceutical companies, healthcare providers, and patients to accelerate the discovery of new treatments for multiple myeloma.

The National Institute of Health’s (NIH) Accelerated Medical Partnership (AMP) program is another collaborative effort aimed at fostering the integration of research and education in medical schools. This initiative seeks to shorten the time it takes for medical students to complete their education and training, thereby addressing the growing demand for physicians and promoting innovation in healthcare. AMP achieves this by offering an accelerated curriculum that combines classroom instruction with early clinical experiences, research opportunities, and mentorship. By partnering with medical schools across the country, NIH aims to shape the future of medical education and meet the evolving needs of the healthcare system.

In conclusion, collaborative efforts in pharmacogenomics and individualized medicine are becoming more prevalent among pharmaceutical companies. Public-private partnerships, consortia, and alliances are examples of such collaborations, allowing companies to leverage shared resources, knowledge, and expertise in pursuit of improved patient care. The NIH’s AMP program represents a similar collaborative initiative, facilitating accelerated medical education through partnerships with medical schools nationwide. These collaborative endeavors hold great promise for advancing medical research, enhancing patient outcomes, and shaping the future of healthcare.

Reference:
Graham, C., Brown, P. J., Goetz, C., Buck, S., & Vaughn, N. (2013). Partnerships in drug development: A review of US public-private partnerships. Journal of Pharmaceutical Health Services Research, 4(1), 55-63. doi:10.1111/jphs.12007

350word, areaDrug, Collaborative, Companies, Discussion, efforts, manage, message, Post, Pursuing, questions, Response, World

Share This Post

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

EHHA 501 Patient Journey Flow Chart

Develop an existing patient journey that crosses the three sectors of care in your organization (the organization is military hospital) Hwo could this be improved ? As a chart flow You are a medical professor in charge of creating college assignments and answers for medical college students. You design and

MDC Gabapentin in the Context of Bipolar Disorder

A new patient presents to your office for treatment of bipolar disorder. In his medical history, he reports that he takes gabapentin prescribed by his primary care provider, but he is not sure what he takes it for. He states he is almost out of his gabapentin and is asking

KEMUL Health & Medical Using Technology to Prevent Patient

Using Technology To Prevent Patient Falls Review the concepts of technology application as presented in the Resources. Reflect on how emerging technologies such as artificial intelligence may help fortify nursing informatics as a specialty by leading to increased impact on patient outcomes or patient care efficiencies. In a project proposal

KEMUL Organizational Conflict and Effectiveness

1. Conflict 2.Relationship Between Organizational Conflict and Effectiveness 3.Common Sources of Organizational Conflict 4.Managerial Response to Conflict 5.Categories of Conflict 6.Stages of Conflict 7.Conflict Resolution Outcomes 8.Common Conflict Resolution Strategies. 9.Compromising 10.Competing 11.Cooperating/Accommodating 12.Common Causes of Organizational Conflict 13.Helpful Tips in Conflict Resolution. 14.Negotiation 15.Types of Alternative Dispute Resolution (ADR)

HSA 405 SU?Healthcare Quality Case Study

Overview In order to complete this case study, refer to this week’s readings for policy information required to analyze and make recommendations on this case. As a healthcare quality fraud analyst, you are responsible for identification of root causes and providing recommendations in an action plan to ensure compliance with

Needs to be 3 paragraphs You are the sole psychologist on

Needs to be 3 paragraphs You are the sole psychologist on what is considered a small-sized base, with a population of approximately 6,000 people, including civilians, dependents, reservists, and active duty personnel. You have an appointment scheduled today with a patient whom you know works within the MTF (Military Treatment

Homework Content ScenarioThe administrator’s presentation,

Homework Content Scenario The administrator’s presentation, based on your briefing, was so well received by the board members that they asked to see a proposal for a hospital-based outpatient facility. In fact, the board suggested that the administrator ask you to take the lead in the project. Your administrator is

The CEO of a health care system has asked you, the system’s

The CEO of a health care system has asked you, the system’s strategic planner, to explain the factors they must consider when deciding the resources that should be devoted to a new facility project. List and describe the factors that determine the location, physical size, projected staffing, and effective décor

AMU HIMA 410 Hospital Data Modeling and Entity Relationship

A data model provides a view of how the data is structured throughout an organization. You’ve been provided with a set of data points from a local hospital. Instructions: Using the data points provided, create a model. Your data model should structure the data to support the business practices of

HIMA 360 AMU Encoder Selection for HIM Director Report

Case Scenario: Part 1: You are the HIM Director at Community General Hospital. As the director, you are in charge of purchasing an encoder for your 20 coders. You have identified the criteria that you will use to make the determination and put it in the grid below. Vendor 1

NUR 3846 BCC Deep Vein Thrombosis Questions

Using the video from Episode 2 on Samantha, answer the following prompts: Prompt 1: Explain in detail the pathogenesis of a DVT (Deep Vein Thrombosis) and how it can lead to a PE (Pulmonary Embolism). Prompt 2: Research and list all the possible treatment options for a DVT. Please correlate

MDC Key Elements of Psychiatric Assessment Discussion Reply

response to post: Discuss the Key elements of Psychiatric assessment and Interviewing of children. Assessing children and adolescents is challenging. A psychiatric assessment can determine if a child is experiencing a disorder or if there are other factors that may be causing their difficulties. Establishing rapport is the first and

MDC Conducting Psychiatric Assessments Discussion Reply

Respond to Ste: Discuss the Key Elements of Psychiatric Assessment and Interviewing of Children When conducting psychiatric assessments and interviewing of children, there are several important elements to consider. According to Sharma et al. (2019), creating a rapport is crucial to building a relationship of trust with children while encouraging

MDC Assessing Childrens Mental Health Discussion Reply

post response Mari: Assessing children and adolescents is challenging. Generally, the child/adolescent in question would not have initiated the consultation or may not be in agreement with the need for a consultation. The consultation may or may not even be sought for the most impairing problem at hand. While children

MU African American Counselors in Training Project

Task summary: You are to do Exploring clinical supervision with African American counselors in Training editing Full description: please write Exploring clinical supervision with African American counselors in Training You are a medical professor in charge of creating college assignments and answers for medical college students. You design and

Few people have not heard about the Food and Drug

Few people have not heard about the Food and Drug Administration (FDA). The COVID pandemic has placed a renewed focus on its role in assuring safety of drug approval. It is not nearly as well known that the FDA is tasked with regulating multiple categories of products. One cannot work in healthcare

MHA 543 UP Health & Medical Generational Work Trait

Work traits vary considerably between various generations. Each individual has a unique manner for interacting with others and solving problems or addressing issues that arise. In this assignment, you will address work trait differences and how these differences might impact the organizational culture and succession planning. Part I: Individual Work

Health & Medical Health Screening Tests Issues and Concerns

Describe what you already know about the module’s topics (if anything) With your limited understanding, how you would answer the module’s guiding question: “Do you think most people undergoing a screening test understand how to assess the benefits and risks of the test?” What other questions does the guiding question

Our Services

Post a 260- to 350-word response to the following questions as a New Message into the discussion area:Drug companies are pursuing collaborative efforts with other companies to manage in the world of p

Expert Solution Preview

Share This Post

Related Questions

Use Our 6 Free Tools